# RPG Phase 13.15 Completion Note

Phase 13.15 is complete as a result-path diagnostics and trace timing bridge implementation.

## Accepted evidence

Accepted evidence source:

- `autoplay-100-n82-travel-location-progression(7).zip`

The evidence showed that report-size hardening and per-run performance output are working, but console interception did not capture the remaining turn failures. The next diagnostic surface needs to come from the saved result payloads themselves.

## What changed

Phase 13.15 added:

- `src/tests/rpg/autoplay/result_path_diagnostics.py`
- `src/tests/rpg/test_ci_phase13_15_result_path_diagnostics.py`
- `docs/plans/rpg_phase13_15_result_path_diagnostics.md`
- `docs/plans/rpg_phase13_15_completion_note.md`

Phase 13.15 updated:

- `src/tests/rpg/autoplay/live_performance_bridge.py`
- `src/tests/rpg/autoplay/survival_report_writer_hook.py`
- `docs/plans/rpg_production_readiness_plan.md`

## Implementation summary

The post-run hook now writes `autoplay-turn-error-diagnostics.json` by scanning saved result artifacts and the latest results ZIP. It records failed result objects, their JSON paths, source artifact paths, error fields, trace keys, and bounded trace payloads.

The live performance bridge now also reads timing summaries from actual result rows, including turn and manual trace summaries.

## Boundary confirmation

This slice did not add provider calls, LLM calls, network calls, live endurance execution in CI, gameplay mutation, UI authority changes, package building in CI, or production readiness claims.

Simulation/runtime remains authoritative. Diagnostics and timing labels remain advisory artifact surfaces only and do not decide gameplay truth.

## Remaining risks

- The 100-turn command must be rerun to confirm result-path diagnostics capture the remaining turn failure source.
- If diagnostics identify a concrete runtime component, the next slice should fix that bounded component.
- Live/provider 1000-turn execution remains pending.
- Production readiness is not claimable.

## Recommended next slice

Continue with:

- Phase 13.16 — rerun 100-turn evidence review after result-path diagnostics.
